US decries the 'free ride' countries with public health systems are getting by negotiating deals for prescription drugs
Key takeaways
- And it’s threatening to impose tariffs if those pricing practices are deemed unfair.
- In most developed countries, drug prices are set or negotiated by the government.
- Robert Kiyosaki says this 1 asset will surge 400% in a year and begs investors not to miss this ‘explosion’
US decries the 'free ride' countries with public health systems are getting by negotiating deals for prescription drugs SAUL LOEB/AFP via Getty Images Vawn Himmelsbach Wed, June 24, 2026 at 11:23 PM GMT+7 6 min read The Trump administration has launched an investigation into Germany’s pharmaceutical pricing, claiming that “persistent underpayment” for drugs is forcing Americans to subsidize research and development (R & D) globally. And it’s threatening to impose tariffs if those pricing practices are deemed unfair.
In most developed countries, drug prices are set or negotiated by the government. In the U.S., pharmaceutical companies set the prices, based more on what the private market can bear.
Robert Kiyosaki says this 1 asset will surge 400% in a year and begs investors not to miss this ‘explosion’